Latest Insider Transactions at Nuvalent, Inc. (NUVL)
This section provides a real-time view of insider transactions for Nuvalent, Inc. (NUVL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nuvalent, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nuvalent, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2022
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,200
-100.0%
|
$71,400
$17.17 P/Share
|
|
Feb 15
2022
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,200
+50.0%
|
$4,200
$1.08 P/Share
|
|
Aug 02
2021
|
Andrew A. F. Hack |
BUY
Open market or private purchase
|
Indirect |
735,000
+17.66%
|
$12,495,000
$17.0 P/Share
|
|
Aug 02
2021
|
Andrew A. F. Hack |
BUY
Conversion of derivative security
|
Indirect |
2,693,014
+50.0%
|
-
|
|
Aug 02
2021
|
James E Flynn Director |
BUY
Conversion of derivative security
|
Indirect |
18,783,622
+28.84%
|
-
|
|
Aug 02
2021
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
897,671
+50.0%
|
-
|